Clinical Trial Update: Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant [Phase 1]

View source ↗

Summary

This update summarizes a Phase 1 trial evaluating busulfan as a conditioning agent for a second stem cell transplant in patients with chronic granulomatous dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Granulomatous Disease, Chronic | Phase 1 | Status: COMPLETED